Source link : https://newshealth.biz/health-news/ianalumabs-success-in-phase-iii-trials-marks-a-turning-point-in-sjogrens-disease/
(MedPage Today) — In the recently reported NEPTUNUS-1 and -2 trials, presented at this year’s American College of Rheumatology (ACR) annual meeting, investigators found that the anti-B-cell activating factor receptor (BAFF-R) antibody ianalumab… Source link : https://www.medpagetoday.com/meetingcoverage/acrexpertroundtable/118909 Author : Publish date : 2025-12-09 16:45:00 Copyright for syndicated content belongs to the linked Source.
The post Ianalumab’s Success in Phase III Trials Marks a Turning Point in Sjögren’s Disease first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-09 16:45:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8